Savvy Updates 5/19/25: Tandem/CapBio Infusion Set Cleared, Test Strips Not Covered by Medicare, Eversense & Sequel/twiist, Abbott Libre Lessens Severity of CV Complications, Call-to-Action to Eliminate Barriers to Access for AIDs, Upcoming CGMs & Patch Pumps, T1Ds Increase Daily Dose of Inhaled Insulin, Tyrosine Kinase 2 (TYK2) Protein Reduces Pancreatic Inflammation, How Much Sugar In Breakfast Foods, Sleep Needs & Your Nationality

Savvy Updates 5/19/25: Tandem/CapBio Infusion Set Cleared, Test Strips Not Covered by Medicare, Eversense & Sequel/twiist, Abbott Libre Lessens Severity of CV Complications, Call-to-Action to Eliminate Barriers to Access for AIDs, Upcoming CGMs & Patch Pumps, T1Ds Increase Daily Dose of Inhaled Insulin, Tyrosine Kinase 2 (TYK2) Protein Reduces Pancreatic Inflammation, How Much Sugar In Breakfast Foods, Sleep Needs & Your Nationality

May 19, 2025 | Advocacy, Diabetes Business, Eating, Featured, Foods, Podcasts, Research News, Technology Updates

In this week’s issue of The Savvy Diabetic:  Tandem/CapBio Infusion Set Cleared (ultimately for extended use to 7 days) Test Strips Not Covered by Medicare Eversense & Sequel twiist Partnership Abbott Libre Lessens the Severity of CV Complications...
Savvy Updates 5/5/2025: Sequel Twiist/Eversense CGM, Adocia AdoShell Immunoprotective Hydrogel for Islets, How To Treat a HYPO, Zucara Therapeutics ZT-01 Once-Daily to Prevent Hypoglycemia, GLP 1s on TCOYD, Mounjaro vs Ozempic, Semaglutide Treats Liver Disease, GLP-1s & Better Sleep, This Is Your Body on Sugar, Why Belly Fats Increases with Aging, Aging T1D & Muscle Loss, New Insulet CEO, Microdosing GLP-1s, UHC’s Stock Drop

Savvy Updates 5/5/2025: Sequel Twiist/Eversense CGM, Adocia AdoShell Immunoprotective Hydrogel for Islets, How To Treat a HYPO, Zucara Therapeutics ZT-01 Once-Daily to Prevent Hypoglycemia, GLP 1s on TCOYD, Mounjaro vs Ozempic, Semaglutide Treats Liver Disease, GLP-1s & Better Sleep, This Is Your Body on Sugar, Why Belly Fats Increases with Aging, Aging T1D & Muscle Loss, New Insulet CEO, Microdosing GLP-1s, UHC’s Stock Drop

May 5, 2025 | Diabetes Business, Eating, Exercise, Featured, Podcasts, Research News, Technology Updates, Videos

In this week’s issue of The Savvy Diabetic:  Sequel Twiist/Eversense CGM Adocia AdoShell Immunoprotective Hydrogel for Islets How To Treat a HYPO Zucara Therapeutics ZT-01 Once-Daily to Prevent Hypoglycemia GLP-1s – One Class of Drugs with Many...
Savvy Updates 4/21/25: Dexcom 15-Day CGM Frequency of Failure, 39 States Push Legislation Against PBM-Pharmacy Ties, Beta Bionics iLet After 2 years, Walking & Heart Health, How Much Protein Do We Need, Vit. K Affects Brain Health, Huge Amounts of Diabetes-Related Waste, Abbott US Diabetes Sales Up 27%, Wearing Socks & Better Sleep

Savvy Updates 4/21/25: Dexcom 15-Day CGM Frequency of Failure, 39 States Push Legislation Against PBM-Pharmacy Ties, Beta Bionics iLet After 2 years, Walking & Heart Health, How Much Protein Do We Need, Vit. K Affects Brain Health, Huge Amounts of Diabetes-Related Waste, Abbott US Diabetes Sales Up 27%, Wearing Socks & Better Sleep

Apr 21, 2025 | Advocacy, Diabetes Business, Featured, Podcasts, Research News, Technology Updates

In this week’s issue of The Savvy Diabetic:  Dexcom 15-Day CGM: 25% May Not Last for 15 Days 39 States Push Legislation Against PBM-Pharmacy Ties to Protect Competition Beta Bionics iLet After 2 years, with Stacey Simms Take a Brisk Walk for Heart Health...
Savvy Updates 4/14/25: DRI “Aggressively Working” on T1D Cure, Microbiome Therapy To Delay T1D Onset, Fully Closed AID Systems Effective, 025 Breakthroughs in D Research, D Distress Linked to Autonomic Symptoms, Medtech Industry Presses for Tariff Exemptions, Hearing & Heart Failure Risk, New Type of D 5, Heat & Kidney Transplant Recipients, Ex-FDA Chief Cites ‘Dysfunctional’ Congress, FTC Chair on PBM Insulin Case, Nursing Home Staffing Mandate Struck Down, Alcohol Changes Fat Levels

Savvy Updates 4/14/25: DRI “Aggressively Working” on T1D Cure, Microbiome Therapy To Delay T1D Onset, Fully Closed AID Systems Effective, 025 Breakthroughs in D Research, D Distress Linked to Autonomic Symptoms, Medtech Industry Presses for Tariff Exemptions, Hearing & Heart Failure Risk, New Type of D 5, Heat & Kidney Transplant Recipients, Ex-FDA Chief Cites ‘Dysfunctional’ Congress, FTC Chair on PBM Insulin Case, Nursing Home Staffing Mandate Struck Down, Alcohol Changes Fat Levels

Apr 14, 2025 | Advocacy, Diabetes Business, Featured, Podcasts, Research News, Technology Updates, Videos

In this week’s issue of The Savvy Diabetic:  Diabetes Research Institute (DRI) “Aggressively Working” on T1D Cure Microbiome Therapy To Delay T1D Onset Fully Closed AID Systems Effective Without Meal Announcements 2025 Breakthroughs in Diabetes...
Savvy Updates 4/7/25: Diabetes Treatment Breakthroughs, Saccharin Kills Multidrug-Resistant Bacteria, D & Bone Health, Avoiding Hypos During Exercise, GlucoSense App

Savvy Updates 4/7/25: Diabetes Treatment Breakthroughs, Saccharin Kills Multidrug-Resistant Bacteria, D & Bone Health, Avoiding Hypos During Exercise, GlucoSense App

Apr 7, 2025 | Diabetes Business, Featured, Podcasts, Research News, Technology Updates, Videos

In this week’s issue of The Savvy Diabetic:  Diabetes Treatment Breakthroughs: Harmine to Stimulate Beta Cell Replication; Sana BioTechnology Islet Transplantation without Immunosuppression, AI-powered insulin delivery system Saccharin Kills...
Savvy Updates 7/15/24: Novo Icodec Rejected by FDA, Is Stevia Safe?, Sucrolose & Environment, BG Changes Impact Cognitive Function, Ypsomed Pump, Islet Cell Replacement Therapy, FTC to Sue 3 Largest PBMs, GO-Pen Creates Equal Access, Medicare Cuts Physician Pay

Savvy Updates 7/15/24: Novo Icodec Rejected by FDA, Is Stevia Safe?, Sucrolose & Environment, BG Changes Impact Cognitive Function, Ypsomed Pump, Islet Cell Replacement Therapy, FTC to Sue 3 Largest PBMs, GO-Pen Creates Equal Access, Medicare Cuts Physician Pay

Jul 15, 2024 | Advocacy, Diabetes Business, Featured, Podcasts, Research News, Technology Updates, Videos

Novo’s once-weekly insulin rejected by FDA by Kristin Jensen for BioPharmaDive.com, 11 July 2024. Novo is one of the world’s premier manufacturers, along with Indianapolis-based Eli Lilly. Both have been working for years to offer patients a more convenient option...
Skip to content